Feed/Investors/Forbion Growth Opportunities Fund

Forbion Growth Opportunities Fund

The rounds this investor is named on, who it invests beside, and where it shows up.

Named on one round in the feed.

Since 2023-11-13

ROUNDS

as lead investor

LED ROUNDS · USD

$68.8M

across 1 round · 1 co-led, split evenly

LATEST ROUND

Series A · $137.6M · 2023-11-13

CO-INVESTORS

named beside it

Rounds

[ 1 ]

The rounds this investor is named on, who it invests beside, and where it shows up.

Company	Round	Amount	Announced	Role
VectorY Therapeutics A clinical-stage biotechnology company pioneering vectorized antibody therapies for neurodegenerative diseases	Series A Developing, 1 source[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it.	$137.6M	2023-11-13	[ LEAD ]